#DAPT after valve-in-valve #TAVI may be associated with a lower one-year incidence of stroke, while no significant difference was observed for other major ischemic and bleeding outcomes or for premature valve deterioration. https://bit.ly/46zU4Gx #GISE46 #JACCINT #CardioSky

We're seeking a visionary leader in CV research to serve as the next Editor-in-Chief of #JACCAdvances. Applicants should have an academic appointment, a strong scholarly record, leadership experience, & knowledge of open access publishing. Apply: https://t.co/u69ewQHR6G

🎥 Dr. Fred Kusumoto shares the importance of clinical guidance beyond traditional #ClinicalGuidelines, & shares takeaways from 🆕 expert consensus decision pathway on tricuspid regurgitation (TR). 📖 Read: https://bit.ly/4ncVbSp #JACC #ACCClinicalDoc #CardioSky #vhdTR @jaccjournals.bsky.social

A recent #JACC study found that 4️⃣ CV risk factors – BP, blood sugar, #Cholesterol, & smoking – could serve as warning signs before cases of #CVD, #HeartFailure, or #Stroke occur. www.cnn.com/2025/09/29/h... @cnn.com

New 2025 ACC scientific statement reviews the role of inflammation in #CVD, covering #atherosclerosis, #heartfailure & #pericarditis. It highlights residual risk, screening, management & new therapies. Get the details in #JACC: https://bit.ly/46ORETq #CardioSky

Selective in vitro enhancement of cardiac myosin motor function and myofilament force generation by danicamtiv prompted clinical evaluation. A short course of danicamtiv was generally well tolerated in participants with #DCM https://bit.ly/4mE3vcM #HFSA2025 #JACC #cvGenetics @jimjanuzzi.bsky.social

Acoramidis 📉 cumulative CV outcomes in #ATTRCM vs placebo, w/ numerical differences by month 1 & 📈 through month 30 (53 events avoided/100 pts). Nearly 1/4 of events occurred in the first 6 months, underscoring the need for timely Tx https://bit.ly/4gLv5DG #HFSA2025 #JACC #CardioSky

Between 2021-2025, relatively few AHFTC fellowship programs matched most applicants. Applicants prioritize markers of hospital reputation & #Hearttx volumes over regional disease burden or geographical considerations. https://bit.ly/4nHnWXP #HFSA2025 #JACCHF #ACCHFT @eirangorodeski.bsky.social

📢 New in #JACC: ACC/AHA methodology statements on: 🔹 Core Principles & Development 🔹 Cost/Value (update) 🔹 FDA Processes Together with Circulation, they provide the framework to keep guidelines rigorous, transparent & responsive. 🔗 Explore the statements: https://bit.ly/3IE4EDc #CardioSky #MedSky

At #UNGA80, experts shared the 2023 #GBDstudy, tracking #CVD trends in 204 countries since 1990. Full insights: https://bit.ly/4pxeDe6 🗨️ Dr. Krumholz: “Data should be a compass, not a mirror. We must focus efforts where they’re needed most. AI can transform care.” #JACC #NHLBI @ihmeuw.bsky.social

New in #JACC: A cross-trial analysis of 3 cardiac amyloidosis #ATTRCM trials reveals time-dependent effects of modern disease-modifying therapies on mortality. Get the details: www.jacc.org/doi/10.1016/... #ATTRMeeting2025 #ATTR2025 #Amyloidosis #CardioSky

A new report in #JACC, published to coincide with a #UNGA80 event, highlights the urgent need to prioritize heart health. #CVD causes 1 in 3 deaths worldwide, driven by population growth, aging, obesity & diabetes. Read the report: www.jacc.org/doi/10.1016/... #GBDStudy #CardioSky #MedSky

Quality measurement was once a breakthrough. But today it’s too slow, too costly, and too disconnected from daily care. It’s time to reinvent it. 🆕 My Editor’s Page in JACC: www.jacc.org/doi/epdf/10.... @jaccjournals.bsky.social @yalemed.bsky.social

A new ECDP addressing "10 issues for the clinician in TR evaluation & management" focuses specifically on patients with secondary TR in the chronic setting & intended to serve as a bridge to a future update of ACC/AHA #VHD guideline. Get the details: https://bit.ly/4ngIbvd #JACC #vhdTR #CardioSky

Young adults with high remnant cholesterol face significantly increased CV risk, even with optimal LDL-C. Findings from a 4.3M nationwide cohort highlight remnant-C as a potent, age-sensitive risk factor needing early preventive strategies. https://bit.ly/46KV4aP #JACC #ASCVD #cvLipids #ACCIntl

Recanalization of radial artery occlusion using distal radial access (DRA) is a safe, effective and reproducible procedure among centers with DRA expertise, according to a study published in #JACCINT. Get the details: www.jacc.org/doi/10.1016/...

Seeking visionary leader in CV research to serve as the next Editor-in-Chief of #JACCAdvances. Applicants should have an academic appointment, strong scholarly record, leadership experience, and knowledge of open access publishing. Apply by Oct 15, 2025: https://bit.ly/47OsBCa

Don’t miss your chance to present your research on cardiology’s premier stage at #ACC26! Now accepting abstracts, complex clinical cases from FITs and physicians, and CV Team abstracts and cases. Submit by 1 pm ET on Sept. 30 https://bit.ly/4gmTC1C #CardioSky #CardioEd

A patient-facing app prototype showed strong comprehension, accurate risk perception & behavioral intention, highlighting its potential to empower patients with actionable health insights. https://bit.ly/429B1A3 #JACCAdvances #HRX2025 #CIED #MachineLearning #HeartFailure #CardioSky

In a new edition of ACC's Cardiology Hour, Dr. Valentin Fuster & a panel of experts break down the top trials released during #ESCCongress, such as ALONE-AF, ODYSSEY-HCM, BaxHTN, & more! 📽️: https://bit.ly/4naa5Ze #JACC #WCCardio #CardioSky #MedSky @accintouch.bsky.social#ESCCongress

❤️ Heart Failure in focus at #ESCCongress. #JACCHF Editor-in-Chief Dr. Biykem Bozkurt highlights key science from Hot Line 2. 📺 Watch her Quick Takes now with #ACCAnywhere TV from ESC Congress in Madrid ⬇️

In persistent #AFib, cryoballoon (CB) ablation was as effective as radiofrequency. Adding posterior wall isolation using CB ablation didn’t improve outcomes, so routine use isn’t supported. https://bit.ly/4n661cf #JACCCEP #ESCCongress #WCCardio #epAblation #CardioSky #MedSky

In this pooled analysis of 2 phase 3 clinical trials, obicetrapib treatment was associated with a reduction in coronary events, evident beyond 6 months of treatment. https://bit.ly/47ljrwK #JACC #ESCCongress #WCCardio #CVD #MACE #cvLipids

ENVAD-HF, a prospective RCT in stable HM3 #LVAD recipients, shows angiotensin–neprilysin inhibition is safe and well-tolerated, paving the way for trials of HF therapies in this population. https://bit.ly/47fJRQn #JACCHF #ESCCongress #WCCardio #LVAD #HeartFailure #CardioSky

EMORI-HCM: Electromechanically optimized right ventricular pacing improves symptoms, exercise capacity and #LVOT gradient in patients with #oHCM. Learn more about this late-breaking clinical trial in #JACC: https://bit.ly/4mznIRP #ESCCongress #WCCardio #CardioSky #MedSky

In a STRIDE post-hoc analysis, #semaglutide 1.0 mg improved functional outcomes in early symptomatic #cvPAD + #T2D regardless of sex. Baseline differences in females underscore the need for sex-specific evaluation in PAD trials. https://bit.ly/4fWwsik #JACC #ESCCongress #WCCardio #QoL

#HFpEF appears to develop as a result of changes in the biology of a person’s internal fat tissue, according to the #Adipokine Hypothesis, a new way of understanding how fat may impact the heart. Get the details: https://bit.ly/45QzO3f #JACC #ESCCongress #WCCardio #CardioSky

In this exploratory prespecified analysis, RSVpreF vaccination was associated with reduced risks of #RSV-related, respiratory, & cardiorespiratory hospitalizations, with similar benefits in patients with or without #heartfailure. https://bit.ly/4mFixzZ #ESCCongress #WCCardio #JACC #CardioSky

Ticagrelor wasn’t superior to BID clopidogrel at 1 month post-#PCI, with similar bleeding, but reduced #MACE in the first 2 weeks. https://bit.ly/46eOmcU #ESCCongress #WCCardio #JACC #CardioSky #MedSky

In patients undergoing #PCI, a personalized #DAPT duration from 3 to 24 months based on a clinical risk score led to a lowered risk of net adverse clinical events than standard care consisting of 12 months of DAPT. https://bit.ly/47pBB0l #JACC #ESCCongress #WCCardio #CardioSky

In #HFrEF, quadruple therapy (ARNi, β-blockers, MRA, #SGLT2i) improves survival. Adding #vericiguat may offer a modest ~0.7-year gain, though findings are exploratory, as they are derived from a secondary endpoint of a single trial https://bit.ly/4mE83Rp #JACC #ESCCongress #WCCardio

In patients with uncontrolled #hypertension, a novel triple single-pill containing candesartan cilexetil, amlodipine, and chlorthalidone improved BP control at 12 weeks and had a reasonable safety profile. https://bit.ly/47QnQru #JACCAdvances #ESCCongress #WCCardio #CardioSky

Navitor valve showed favorable safety & performance at 30 days & 12 months in treating pts w/ symptomatic, severe AS who are at low or intermediate surgical risk, supporting its expanded use in low- & intermediate-risk pts https://bit.ly/4n4Bhs7 #JACCINT #ESCCongress #WCCardio #vhdAS #CardioSky

In this exploratory analysis, treatment with low-dose colchicine was associated with an attenuated annual clonal growth in TET2 CH. These findings suggest the potential for colchicine to curb the proliferative advantage of key CH driver mutations https://bit.ly/3HWJL5M #ESCCongress #WCCardio #JACC

📢 New AHA/ACC statement reviews the rationale for using the Predicting Risk of #CVD Events equations, the ≥7.5% 10-yr risk threshold, & population-level impact. Get the details in #JACC: https://bit.ly/3HJhWxV #CardioSky #Hypertension #cvPrev @accintouch.bsky.social#CVD

🚨 Save your spot! 🚨 Join the #JACCJournals and The Lancet editorial boards for a special reception during #ESCCongress 2025. 🍸 Cocktails & hors d'oeuvres 📅 Sunday, Aug 31 | 5:30–7 p.m. CEST 📍 The Palace Madrid, Neptuno Room RSVP: https://bit.ly/3JCIaTc #WCCardio #CardioSky #MedSky @thelancet.com#JACCJournals

🚨 Hot off the press! 🚨 📚 Explore the latest clinical research from the #JACCJournals family, published alongside major presentations at #ESCCongress 2025 with #WCCardio. 👉 Dive in: t.co/k0ilGpIOOK #CardioSky #MedSky @accintouch.bsky.social

The ACC’s new Clinical Guidance urges immunizations for adults with heart disease, protecting against the #flu, #COVID19, #RSV, and other vaccines shown to benefit heart health. www.jacc.org/doi/10.1016/... #JACC #cvPrev #CVD #CardioSky #MedSky

📢 Call for Submissions! #JACCCaseReports is now accepting content for a Special Issue on Complex Heart Rhythm Disorders in Asian Patients—covering diagnosis + all treatment approaches (medical, EP, surgical). 👉 Submit your work today: www.jacc.org/call-for-pap... #CardioSky #MedSky #ACCIntl

2025 AHA/ACC/Multisociety #ClinicalGuideline on #HBP reviews the latest evidence, global impact, team-based care, & a new risk calculator. This Guideline-at-a-Glance highlights practice-changing recommendations to accelerate adoption. https://bit.ly/47tyqo6 #JACC #Hypertension #CardioSky #MedSky

🚑 #HeartFailure drives major #EMS burden but is often missed. In 25k+ statewide dyspnea cases, >50% had no prior HF Dx & just 24% were identified pre-hospital. Mortality was high. Early action matters. www.jacc.org/doi/10.1016/... #JACCHF #CSANZ2025 #CardioSky

Pop-up screening for #ASCVD risk held at community pharmacies & large-scale sporting events can identify people w/ uncontrolled CV risk factors, according to a study published in #JACC & simultaneously presented at #CSANZ2025. www.jacc.org/doi/10.1016/... #cvPrev #CardioSky

The new AHA/ACC/Multisociety #ClinicalGuideline on high #bloodpressure provides updated recommendations for clinicians on the prevention, detection, evaluation, and management of high blood pressure in adults. Get the details in #JACC: www.jacc.org/doi/10.1016/... #Hypertension #CardioSky #MedSky

Combined #TAVR and VT ablation is feasible and can effectively treat 2 life-threatening problems in high-risk patients. A team-based, individualized approach is essential for procedural success. www.jacc.org/doi/10.1016/... #JACCCaseReports #epAblation #vhdAS

Using portable high-efficiency particulate air purifiers at home can significantly lower systolic #bloodpressure in adults with elevated baseline readings — even in areas with relatively low overall #AirPollution levels www.jacc.org/doi/10.1016/... #JACC #Hypertension #AirPurifier #CardioSky

🆕 ACC scientific statement on the Dx & management of #pericarditis addresses diagnostic & therapeutic advances in acute & recurrent pericarditis & their complications, employing a multimodality imaging-guided therapeutic approach. Get the details in #JACC: www.jacc.org/doi/10.1016/... #CardioSky

The @nytimes.com spotlights the new #JACC issue on cardiac #amyloidosis: “New research shows how vutrisiran improves heart relaxation, muscle damage, and more.” Read the full story + issue: www.jacc.org/toc/jacc/86/6 NYT: www.nytimes.com/2025/08/04/w...

We’re drowning in data, but are we helping patients? In this #JACC Editor’s Page, Dr. @hmkyale.bsky.social challenges us to ask better questions in #HeartFailure care. If you think you know HF, read this: www.jacc.org/doi/10.1016/... #CardioSky #MedSky

New #JACCBTS issue dives into the overlooked cardiohepatic axis, highlighting heart-liver crosstalk in metabolic syndrome, #heartfailure, and cirrhosis. Explore how this interplay is reshaping our understanding of heart health: www.jacc.org/toc/basic-tr... #CardioSky #MedSky

Compared with TAVs and BAVs type 1 (BAV-1; 1 raphe), BAV type 0 (BAV-0; no raphe) was associated with a better long-term prognosis among patients with severe AS undergoing #TAVR procedures. www.jacc.org/doi/10.1016/... #JACCINT #vhdAS